Beta Bionics reported total assets of $292.39M and total liabilities of $36.02M for the quarter ended Jun 2026, down 11.4% year over year. This balance sheet covers 11 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Current Assets | |||||||||||
| Cash & EquivalentsCash & Equiv. | 26.57M | 22.07M | 13.03M | 17.48M | 30.43M | 42.45M | 35.08M | 38.48M | 31.58M | 30.21M | 44.32M |
| Short-term InvestmentsInvestments (Current) | 70.18M | 73.14M | 189.02M | 214.65M | 190.20M | 187.55M | 169.31M | 136.17M | |||
| Cash & Current Investments | 96.75M | 22.07M | 13.03M | 17.48M | 103.58M | 231.47M | 249.72M | 228.69M | 219.12M | 199.52M | 180.49M |
| Receivables - NetNet Receivables | 4.49M | 12.11M | 9.18M | 11.51M | 11.68M | 17.27M | 15.91M | 18.23M | |||
| Receivables | 4.49M | 12.11M | 9.18M | 11.51M | 11.68M | 17.27M | 15.91M | 18.23M | |||
| Inventory | 1.25M | 13.32M | 15.73M | 17.32M | 20.37M | 21.72M | 23.73M | 23.92M | |||
| Prepaid Assets | 1.18M | 4.03M | 5.65M | 7.64M | 9.43M | 9.84M | 8.89M | 8.47M | |||
| Current Assets | 103.62M | 132.92M | 261.92M | 286.07M | 270.03M | 267.90M | 247.99M | 231.03M | |||
| Non-Current Assets | |||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 2.48M | 4.78M | 5.51M | 6.46M | 7.38M | 8.60M | 10.16M | 10.75M | |||
| Long-Term Investments | 64.00M | 31.15M | 45.33M | 45.43M | 39.87M | 44.65M | |||||
| Other Non-Current Assets | 0.12M | 0.10M | 0.10M | 0.10M | 5.05M | 0.10M | 0.10M | 0.18M | 0.18M | 0.18M | 0.14M |
| Non-Current Assets | 6.42M | 16.72M | 76.11M | 43.90M | 60.02M | 60.84M | 56.43M | 61.35M | |||
| Assets | 110.04M | 149.65M | 338.02M | 329.97M | 330.05M | 328.74M | 304.42M | 292.39M | |||
| Liabilities | |||||||||||
| Current Liabilities | |||||||||||
| Accounts Payables | 1.17M | 2.85M | 3.45M | 3.42M | 4.46M | 5.00M | 2.32M | 5.35M | |||
| Payables | 1.17M | 2.85M | 3.45M | 3.42M | 4.46M | 5.00M | 2.32M | 5.35M | |||
| Accumulated Expenses | 8.13M | 15.83M | 10.56M | 13.40M | 17.61M | 22.43M | 17.33M | 17.19M | |||
| Current Leases | 1.22M | 1.53M | 1.52M | 1.52M | 1.98M | 1.94M | 1.84M | 1.59M | |||
| Current Deferred Revenue | 0.09M | 0.94M | 0.95M | 1.14M | 1.34M | 1.56M | 1.71M | 1.88M | |||
| Total Current Liabilities | 10.61M | 21.15M | 16.49M | 19.49M | 25.39M | 30.92M | 23.19M | 26.02M | |||
| Non-Current Liabilities | |||||||||||
| Non-Current Deffered Revenue | 0.26M | 1.86M | 2.33M | 2.67M | 2.99M | 3.30M | 3.35M | 3.45M | |||
| Preferred Stock Liabilities | 261.71M | 261.71M | 261.71M | 261.71M | 321.37M | ||||||
| Operating Leases | 3.00M | 5.73M | 5.45M | 5.17M | 5.71M | 5.37M | 5.07M | 4.92M | |||
| Other Non-Current Liabilities | 37.57M | 44.90M | 0.40M | 1.01M | 1.21M | 1.55M | 1.56M | 1.63M | |||
| Total Non-Current Liabilities | 13.86M | 28.73M | 23.87M | 27.33M | 34.08M | 39.59M | 31.61M | 34.39M | |||
| Total Liabilities | 51.43M | 214.32M | 221.21M | 228.85M | 73.63M | 24.27M | 28.34M | 35.29M | 41.13M | 33.17M | 36.02M |
| Shareholder's Equity | |||||||||||
| Common Equity | -203.10M | -214.32M | -221.21M | -228.85M | -245.36M | 313.75M | 301.63M | 294.76M | 287.61M | 271.25M | 256.37M |
| Liabilities and Shareholders Equity | 110.04M | 149.65M | 338.02M | 329.97M | 330.05M | 328.74M | 304.42M | 292.39M | |||
| Retained Earnings | -229.66M | -296.74M | 638.90M | 643.74M | 650.87M | 657.14M | 663.17M | 671.99M | |||
| Treasury Shares | 12.88M | 12.88M | 12.88M | 12.88M | 17.23M |